Although further studies are needed to elucidate the exact molecular mechanisms underlying the combined deleterious actions of macrophages and microglia in ALS, our data suggest that CSF1R signalling could be a novel therapeutic target in ALS. This evidence concerns the gene CSF1R and amyotrophic lateral sclerosis.